fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Ajanta Pharma Ltd

Ajanta Pharma Ltd

Updated on February 19, 2020

Stock/Share Code - AJANTPHARM

Ajanta Pharma is primarily involved in development, manufacturing and marketing of speciality pharmaceutical finished dosages.(Source : 201903 Annual Report Page No: 132)

Below is the details of AJANTPHARM Ajanta Pharma Ltd

Market Cap₹8,699 Cr.
Current Price ₹978.6 as on 10 Dec 19
52 Week High / Low Price₹1,204.45 / ₹825
Face Value₹2
Stock P/E22.78
Book Value₹245.48
Dividend Yield0.91 %
ROCE25.22 %
ROE19.24 %
Sales Growth (3yrs)4.05 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Formulations
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has a good return on equity (ROE) track record: 3 Years ROE 26.07%
Cons: The company has delivered a poor growth of 9.82% over past five years.

Ajanta Pharma Ltd Price Chart

Ajanta Pharma Ltd Price Chart

Ajanta Pharma Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Ajanta Pharma 22.78 ₹8,699.08 Cr. 0.91 ₹120.7 Cr. 16.72 20.24 559.45 25.22
2. ERIS Lifescience ₹475.8 20.38 ₹6,338.29 Cr. 0.00 ₹92.71 Cr. 8.66 7.81 284.80 26.43
3. Caplin Point Lab ₹299.55 11.70 ₹2,375.18 Cr. 0.70 ₹57.27 Cr. 31.66 45.77 227.20 48.53
4. Bliss GVS Pharma ₹155.1 13.64 ₹1,482.58 Cr. 0.70 ₹30.98 Cr. -25.28 -8.02 210.12 26.90
5. Hester Bios ₹1,561.5 32.62 ₹1,333.11 Cr. 0.70 ₹6.52 Cr. -6.46 3.34 44.20 26.65
6. Amrutanjan Healt ₹454.95 47.87 ₹1,304.86 Cr. 0.48 ₹8.4 Cr. 29.43 20.56 74.81 25.42
7. Medicamen Biotec ₹114.95 30.33 ₹374.93 Cr. 0.31 ₹3.84 Cr. 7.87 9.33 35.52 20.15
8. Lincoln Pharma. ₹168 6.95 ₹341.9 Cr. 0.88 ₹18.91 Cr. 26.07 9.83 112.69 22.58

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ajanta Pharma Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019
Sales509418398469501463442465452414546559
YOY Sales Growth %19.98%2.95%-4.77%-1.8%-1.54%10.54%11.06%-0.82%-9.77%-10.61%23.48%20.24%
Expenses333285288312347347301323321346406410
Material Cost %25.13%21.19%20.1%22.73%23.68%20.34%18.69%19.99%23.14%27.08%29.96%30.66%
Employee Cost %13.62%16.51%20.05%17.51%16.81%20.92%21.64%20.75%22.16%23.48%19.67%18.98%
Operating Profit17513311015715411514114213167140149
OPM %34%32%28%34%31%25%32%31%29%16%26%27%
Other Income51155865669171334038
Interest000000000014
Depreciation151913141416171718182222
Profit before tax21113010215120410519314212652156161
Tax %19%17%25%29%19%26%22%27%24%20%21%25%
Net Profit17110877108165781511049541124121
EPS in Rs19.4212.278.7212.2418.708.9217.1411.8310.854.7014.1713.83
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales2853193824575998391,1101,3561,5741,8041,8251,7731,971
Sales Growth %19.42%12.1%19.6%19.73%31.07%40.06%32.26%22.19%16.03%14.66%1.16%-2.89%%
Expenses2382603103684816327648851,0501,1661,2791,2911,484
Material Cost %48.63%39.98%39.07%40.03%36.34%35.75%31.32%28.06%26.31%24.38%21.87%22.12%%
Manufacturing Cost %3.8%4.7%4.05%3.5%4.2%4.58%4.1%5.02%6.86%6.44%9.06%8.13%%
Employee Cost %9.46%11.89%10.99%14.48%14.55%13.75%13.27%13.74%14.94%14.95%18.78%21.97%%
Other Cost %21.67%24.71%27.18%22.39%25.19%21.22%20.18%18.4%18.59%18.86%20.32%20.62%%
Operating Profit47607190118207346472524638547481487
OPM %16%19%19%20%20%25%31%35%33%35%30%27%25%
Other Income-011267182885637310294
Interest1522191614188541006
Depreciation7132024313342494359577080
Profit before tax2526345280164313445563641562513495
Tax %28%18%15%10%17%38%29%31%25%22%24%24%
Net Profit1821294666101221306422500428392381
EPS in Rs1.952.353.145.137.345.5624.3113.6147.7056.5148.3344.6743.55
Dividend Payout %17%14%14%13%13%15%16%17%17%23%0%20%

Compounded Sales Growth

  • 10 Years:: 18.70%
  • 5 Years:: 9.82%
  • 3 Years:: 4.05%
  • TTM:: 5.34%

Compounded Profit Growth

  • 10 Years:: 33.77%
  • 5 Years:: 12.20%
  • 3 Years:: -2.51%
  • TTM:: -23.30%

Return on Equity

  • 10 Years:: 54.15%
  • 5 Years:: 0.73%
  • 3 Years:: -18.92%
  • 1 Year:: -14.69%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Share Capital121212121212181818181818
Equity Capital11.811.811.811.811.811.817.6717.6817.6917.6917.6917.54
Reserves1221401642042603445197691,1141,4861,9142,125
Borrowings1652402031581901231297168000
Other Liabilities556687107157196215230220257381410
Trade Payables38.7146.9966.5967.59105.92130.04123.57128.89164.42169.6247.07239.49
Total Liabilities3544584664816196768801,0881,4201,7612,3132,553
Fixed Assets941301612062372632612714335731,0371,162
Gross Block122.38171.61221.75290.34351.34410.03449.57510.92679.21843.351379.381571.54
Accumulated Depreciation28.4941.4260.984.15114.78147.3188.17239.6246.38270.42342.69409.52
CWIP245547173129417024033961261
Investments17171717171979779419920183
Other Assets2202562412403633824465696536501,0141,046
Inventories91.198.98105.1696.12162.35143.51148.77153.05189.78179.28317.37414.26
Trade receivables83.1396.9285.575.76125.42135.19177.09240.85350.48336432.19423.38
Cash Equivalents4.917.315.239.315.0825.1129.08105.6921.4422.8438.6735.87
Loans n Advances40.5952.6645.0122.518.0422.6643.8455.6665.7667.37145.4142.71
Other Assets etc00036.751.8455.547.4314.1425.3944.0280.5630.05
Total Assets3544584664816196768801,0881,4201,7612,3132,553

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity16349910839206190263277537219312
Profit from operations46.8861.1273.1591.21126.4208.03347.55479.06540.69680.81562.65501.74
Working Capital Changes-27-22.8831.5826.16-70.5528.73-157.84-80.75-111.94-13.32-221.01-86.63
Taxes paid-3.9-4.44-5.35-9.74-17-31.10-135.39-152.08-130.59-122.47-103.03
Cash from Investing Activity-56-81-42-50-50-98-176-146-139-340-201-137
Fixed Assets Purchased-55.85-81.15-42.34-41.66-57.1-89.53-124.28-108.68-295.03-298.8600
Fixed Assets Sold0.080.430.160.080.140.243.9600.423.210.110.62
Investments purchased-0.2-0.3300000-40.04-219-355.73-225.12-269.22
Investments sold00006.760035.54215.39267.78235.7392.45
Cash from Financing Activity3950-59-6112-96-20-101-128-198-1-181
Proceeds from Shares0000000.010.010.01000
Proceeds from Borrowings56.5875.1602.9249.954.39.28034.12000
Repayment of Borrowings00-36.93-43.4-17.86-121.16-3.8-58.08-24.08000
Interest Paid-15.01-22.09-18.94-16.07-13.64-18.89-8.19-5.11-4.2-1.25-0.24-0.41
Dividends Paid-2.33-2.92-2.91-4.07-6.78-8.73-14.61-35.09-122.77-114.19-0.3-79.12
Net Cash Flow-12-2-3011-6169-118-6

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %15%14%14%18%22%39%56%60%55%48%33%25%
Debtor Days10711182607659586581688687
Inventory Turnover3.563.363.744.544.645.497.598.999.189.787.354.85

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Ajanta Pharma Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.